MDxHealth SA (NASDAQ:MDXH) Sees Large Decrease in Short Interest

MDxHealth SA (NASDAQ:MDXH) was the target of a large drop in short interest in January. As of January 15th, there was short interest totalling 24,700 shares, a drop of 25.6% from the December 31st total of 33,200 shares. Based on an average daily trading volume, of 139,000 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.1% of the shares of the stock are sold short.

Hedge Funds Weigh In On MDxHealth

Several large investors have recently modified their holdings of the stock. OneDigital Investment Advisors LLC lifted its position in MDxHealth by 15.3% in the third quarter. OneDigital Investment Advisors LLC now owns 57,726 shares of the company’s stock worth $120,000 after buying an additional 7,656 shares during the last quarter. Maven Securities LTD purchased a new stake in shares of MDxHealth in the third quarter valued at $208,000. MVM Partners LLC lifted its holdings in shares of MDxHealth by 3.3% in the 3rd quarter. MVM Partners LLC now owns 4,700,457 shares of the company’s stock worth $9,706,000 after acquiring an additional 150,000 shares during the last quarter. Finally, Perkins Capital Management Inc. boosted its stake in shares of MDxHealth by 70.7% during the 3rd quarter. Perkins Capital Management Inc. now owns 747,375 shares of the company’s stock worth $1,555,000 after purchasing an additional 309,500 shares during the period.

Analysts Set New Price Targets

Several analysts have recently issued reports on MDXH shares. Lake Street Capital started coverage on MDxHealth in a report on Thursday, October 31st. They set a “buy” rating and a $7.00 price objective on the stock. Piper Sandler decreased their price target on shares of MDxHealth from $8.00 to $6.00 and set an “overweight” rating on the stock in a research note on Thursday, November 7th.

MDxHealth Price Performance

Shares of MDXH stock opened at $1.91 on Friday. MDxHealth has a 1 year low of $1.55 and a 1 year high of $4.15. The stock’s 50 day simple moving average is $2.11 and its two-hundred day simple moving average is $2.32. The company has a debt-to-equity ratio of 3.14, a quick ratio of 1.45 and a current ratio of 1.54.

About MDxHealth

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.